Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:40:09.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical trial for Recurrent Plasma Cell Myeloma, including the addition of a new registry identifier and collaborators, while significant details about the trial's objectives and treatment regimen have been removed.
    Difference
    42%
    Check dated 2025-04-16T01:17:05.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 25, 2025.
    Difference
    0.3%
    Check dated 2025-04-08T19:47:31.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The webpage has added several new dates and a document related to informed consent from M.D. Anderson Cancer Center, while removing outdated dates and a notice about service performance issues.
    Difference
    4%
    Check dated 2025-03-03T16:22:40.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T08:58:03.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T02:34:11.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.